SIGN Pakistan Dr. Arshad Altaf. Objectives of the Presentation zOverview of burden of disease in Pakistan because of unsafe injection practices zPresent.

Slides:

Advertisements

Similar presentations

India Injection Safety Coalition. If you have an apple and I have an apple and we exchange these apples then you and I will still each have one apple.

Advertisements

February Dakar, Senegal

Analysis of the National Liver Disease State of the art THEBERA Theodor Bilharz into the European Research Area FP7 ERAWIDE INCO Project Sanaa.

Managing Sharps Waste In Cambodia SIGN Meeting, 25 October 2002 Cambodiana Hotel, Phnom Penh Dr. Chea Kim Ly, Deputy Director National Immunization Program.

Systematic documentation of success stories Dr. Arshad Altaf SIGN.

Always practice proper hand hygiene and change gloves between each person. Label each individual piece of equipment with the resident’s name to prevent.

URBAN HEALTH INSTITUTE Urban Health Institute is an initiative of Aman Healthcare Services providing Basic and Advanced Medical trainings to Healthcare.

Injection Practices in Mongolia Results and Outcomes of the Rapid Assessment of Injection Practices Dr G. Soyolgerel Dr G. Soyolgerel Ministry of Health.

Synergy and Partnership for Injection Safety: the Senegal experience Jules Millogo, MD, MSc Immunization Advisor BASICS II A USAID-financed project administered.

HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.

V.E.I.L. Liver Cancer Prevention. 1. Vaccination Birth dose + 2 Universal for those not already chronics Screening pregnant women Catch up vaccination.

Date: April 24, 2007 Role of the Education Sector in Road Safety National Road Safety Conference.

Plan of Action to improve injection Safety Within the EPI.

SIGN Rapid Assessment Survey Northern Areas, Pakistan Lubna Samad, MRCS, FCPS Pediatric Surgeon National Institute of Child Health.

An update on HIV/AIDS and STDs in Pakistan: epidemiological trends over the last decade Sharaf Ali Shah MBBS, Ashraf Memon MBBS, Omar Khan MD, Sten Vermund.

for pregnant women and new moms

Health Promotion at work to build a healthier nation1 Health Promoting Schools Initiative is alive and well in Mpumalanga Heila Jooste Deputy Director:

A Webinar Hosted by The National Harm Reduction Coalition The National Black Leadership Commission on AIDS The Coalition for Positive Health Empowerment.

EVALUATION OF A SAFE INJECTION PROJECT IN UZBEKISTAN Dr. Erkin I. Musabaev Institute of Postgraduate Medical Education, Tashkent Uzbekistan Health Ministry.

DELAWARE HEALTH AND SOCIAL SERVICES Division of Public Health Public Health and PCMH Karyl Rattay, MD, MS Director Delaware Division of Public Health.

Hepatitis C Education & Awareness. Women In Government Women In Government Foundation, Inc. is a national, non-profit, non-partisan organization of women.

SANTANA P. ABRAVANEL L., AUBERT JP.PICARD H. GELLY J. FRARIER M. 1 PREVAC A An evaluation of preventive Hepatitis A vaccination in risk groups WONCA EUROPE.

National policy on Hepatitis B at the Workplace

Global Health Diplomacy: Advancing Health Literacy World Health Communication Associates World Health Organization - Geneva 18 May 2009 Scott C. Ratzan,

Safer Needle Devices: Protecting Health Care Workers.

Harold S. Margolis, M.D. Division of Viral Hepatitis

1 Dr.I.A.Joshua 2 Dr JG Makama 3 Dr A Oyemecho 1 Department of Community/ 2 Department of Surgery Kaduna State University, Kaduna, Nigeria 3 Department.

JCAHO UPDATE June The Bureau of Primary Health Care is continuing to encourage Community Health Centers to be JCAHO accredited. JCAHO’s new focus.

Prevention and Control of Viral Hepatitis Infection: WHO Framework for Global Action Prevention and Control of Viral Hepatitis Infection: WHO Framework.

Safe and Appropriate Use of Injection Activities of WHO’s Department of Blood Safety and Clinical Technology (BCT) Yvan Hutin Annual SIGN Meeting New Delhi.

FHM TRAINING TOOLS This training presentation is part of FHM’s commitment to creating and keeping safe workplaces. Be sure to check out all the training.

Cynthia Baur, Ph.D. Senior Advisor, Health Literacy August 23, 2011 The National Action Plan to Improve Health Literacy Office of the Director Office of.

Safe Immunization Practices and Prevention of Hepatitis B and C Susan Mackay Behaviour Change Project Safe Injection Global Network.

Making the Connection: Intimate Partner Violence (IPV) and Public Health Linda Chamberlain, PhD MPH © 2010 The Family Violence Prevention Fund

Hepatitis B - Sexually Transmitted Infection - Infects the liver and causes inflammation - About 1/3 people in the world have Hepatitis B - Can lead to.

GAVI/Vaccine Fund Support to Improve Injection Safety On behalf of the Injection Safety sub-group.

MEDICAL LABORATORY TECHNOLOGY What will I do? Perform tests on human blood, tissue and fluid Be a part of the health care team Help the doctor diagnose.

Collaborating to evaluate. Who could your collaborators be? Collaborators ?

The Australian Model for Home Medicines Review Dr Tim Chen Faculty of Pharmacy 9 th Commonwealth Pharmaceutical Association Conference.

21/4/2008 Evaluation of control measures 1. 21/4/2008 Evaluation of control measures 2 Family and Community Medicine Department.

Public Perceptions about Injections and Private Sector Injection Practices in Central Nepal Mahesh Bhattarai and Scott Wittet.

Injection practices among medical practitioners working at private clinics in Karachi. Shair Muhammad Hazara BSc N, MSBE Nursing Instructor College of.

Primary Care Model Program General practitioners’cluster Gergely Fürjes MD.

San Francisco Hep B Free: Physician Engagement November 16, 2015 Stuart Fong, MD Chinese Hospital, San Francisco, CA

A Pilot Intervention To Improve Injection Practices In The Informal Private Sector in Karachi, Pakistan Mubina Agboatwalla (1) Yvan Hutin (2) Steve Luby.

Prevention of Blood-Borne Pathogen Transmission in Egypt Ministry of Health and Population Arab Republic of Egypt.

Improvement of Injection Safety in Burkina Faso, JF. Aguilera, J. Fitzner, A. Yaméogo, Y. Hutin.

Estimating the Global Burden of HCV Infections Associated with Unsafe Health Care Injections Anja Hauri 1, Gregory Armstrong, 2 Yvan Hutin 1 1. WHO Headquarters,

Hepatitis C in Pakistan

Hepatitis C in Egypt Seif Tamer Ahmed Naser. What is it? Liver disease caused by Hepatitis C virus Can range from mild illness lasting a few weeks to.

Vaccines & Biologicals (V&B) Cost-effectiveness of safe injection policies: Study rationale and proposed methodology Ulla Kou, WHO SIGN meeting in New.

Consumer and Provider Education and Engagement Breakout Session Betsy Abramson, Wisconsin Coalition Against Domestic Violence Alison Bergum, UW Population.

Documenting (Driving) Progress in Immunization Injection Safety Philippe Duclos, WHO Presented at the SIGN annual meeting, Cairo, Egypt, Oct th,

Bulgarian National Hepatitis Plan and Compassionate Use Regulations Dr. Stanimir Hasardzhiev Executive Director, ELPA Chairperson, Hepasist REPUBLIC OF.

From discovery to cure in 25 years -- the Hepatitis C story Mel Krajden MD, FRCPC Medical Head, Hepatitis Acting Medical Director, Public Health Laboratory.

Abstract Problem Statement: As in many former socialist economies, anecdotal reports suggested that injections were overused to administer medications.

Dr Michelle Webb Renal Consultant, Associate Medical Director Patient Safety, East Kent Hospitals University NHS Foundation Trust and Co-lead for Sepsis.

HEALTH LITERACY ASSESSMENT IN PAKISTAN Preliminary Results DR. SHAHZAD ALI KHAN MBBS, MBA, MPH, FRSPH, PhD HEAD OF THE DEPARTMENT OF HEALTH MANAGEMENT.

Comments to the FDA on Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription Marissa Schlaifer, RPh Director of Pharmacy.

Logez S, Hutin Y, Somda P, Thualt J, Holloway K

A qualitative assessment of factors impacting adoption and implementation of USPSTF age-based hepatitis C virus screening recommendations Amy B. Jessop,

Treating Hep C with Novel Agents

Comments to the FDA on Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription Marissa Schlaifer, RPh Director of Pharmacy.

Hepatitis B Hepatitis B is a pathogen, which causes liver disease and inflammation of the liver.

An Interprofessional Perspective on the Safe and Appropriate Use of Opioid Analgesics.

Recognising sepsis and taking action

Blood borne viral hepatitis action in Wales

QUALITY: SAFE CARE Prescription of Potentially Unsafe Medications Among Elderly Beneficiaries, by Hospital Referral Regions, 2007 Percent of elderly Medicare.

The comprehensive process for responding to patient safety incidents at the University of Illinois Medical Center at Chicago. The comprehensive process.

Presentation transcript:

SIGN Pakistan Dr. Arshad Altaf

Objectives of the Presentation zOverview of burden of disease in Pakistan because of unsafe injection practices zPresent activities of SIGN Pakistan zFuture plan

Burden of diseases in Pakistan zStudies in Pakistan have found hepatitis C : y60% hepatitis among liver cancer patients (Ahmed et al., 1995) y51% among beta thalassemia major patients (Ahmed et al., 1995) y46% among chronic liver disease patients (Mujeeb et al., 1998) y18% among cirrhotic patients (Mujeeb et al., 1998) y20% among commercial blood donors (Mujeeb et al., 1998)

Unsafe Injection Practices z1993: Luby et. al. y6.5% antibodies positive for hepatitis C in Hafizabad, Pakistan z1994: Luby et al. yFollow up case control study to identify risk factors yPositive individuals were 8.2 times more likely to receive > 5 injections per year

Unsafe Injections Practices z1995: Aamir Javed Khan et al., yInvestigated relationship between hep B & C and injections in peri urban Karachi y44% hepatitis C positive ythose who received more injections were more likely to be hepatitis C infected y94% of the needles/syringes were reused

Unsafe Injections Practices z1995: Reaglow et al., KAP study y49% received one or more injections at their last visit to health practitioner y35% received 10 or more injections in the last year y64% felt that injections are more powerful

Creation of SIGN Pakistan FIRST NATIONAL SYMPOSIUM zFirst national symposium on Safe Injection and Blood Practices in Pakistan on Feb 15, 2000 zObjectives: yProvide a forum to discuss ideas yIdentify persons and process to develop assessment protocol yCollect input for intervention from those who have conducted studies yFoster formation of Safe Injection working group

Formation of SIGN Pakistan zSIGN Pakistan Working Group formed zMaillist created zFirst national meeting “Partners in Injection Safety” on June 17, 2000 zObjectives: yFormal announcement of SIGN Pakistan yTo identify national stakeholders

SIGNPAK Working Group zThe Aga Khan University zSindh AIDS Control Programme, Government of Sindh zHOPE

National Stakeholders zNational Institute of Health, Islamabad zWHO zUNAIDS zWorld Bank zBecton Dickinson zEPI (Expended Programme of Immunization) zUNICEF zCIET International zPPHF (Pakistan Public Health Foundation)

Development of Injection Assessment Tool zTraining workshop organized in Karachi (collaborating with SIGN-Geneva) zDr. Anne Reeler-Medical Anthropologist zDevelopment and assessment of tool in Karachi zCapacity building

Findings from Initial Assessment yTarget groups: Community & patients, health care providers, dispensers, vaccinators yFindings: xCommunities and patients knew about disposable syringes xPatients rely on doctor for prescription xThey want fast relief xCheaper to get injections xNot aware of hepatitis B or C, aware of pain/abscesses

Findings continued zGeneral practitioners: yInjections are important to stay in business yCost of prescription with and without injection is the same yNo consensus on who initiates injections y80-100% patients get at least one injection yNo health information given to patients

Action Plan yResearch yQualitative assessment in all four provinces yResources available for one province (SINDH) yQuantitative survey in an intervention area yDevelop appropriate health messages

Action Plan yAdvocacy ySensitize policy planners yDisposable medical devices ordinance 2000 yManufacturers-cheap technologies yAdvocacy seminars/workshops yNATIONAL COLLABORATORS

Action Plan zIntervention: zFour Ps yPhysicians yPatients yPopulation yPress